Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Artificial Organs|March 1, 1997
Experience of clinical use of the Odstock dropped foot stimulatorJ Burridge, P Taylor, S Hagan, et al.
Journal of Rehabilitation and Assistive Technologies Engineering|June 13, 2019
The use and effect of video game design theory in the creation of game-based systems for upper limb stroke rehabilitationN Barrett, I Swain, C Gatzidis, et al.
Paraplegia|April 1, 1992
The effectiveness of a pressure clinic in preventing pressure soresH Dover, W Pickard, I Swain, et al.
Journal of the Royal Society of Medicine|February 1, 1995
Induction of labour using prostaglandin E2 gel: the effect of changing the time of first insertionD A Somerset, T Das-Munshi, B Godman, et al.
Artificial Organs|June 23, 1999
Clinical audit of 5 years provision of the Odstock dropped foot stimulatorP Taylor, J Burridge, A Dunkerley, et al.
Leukemia Research|May 4, 2024
Donor Lymphocyte Infusion (DLI) post allogeneic stem cell transplant (allo-SCT) in Acute Myeloid Leukemia (AML) and High-Grade Myelodysplastic Syndrome (MDS). A longitudinal retrospective study using peripheral blood (PB) CD34+ and CD3+ donor chimerism (DC) monitoringTishya Indran, Tongted Das, Jenny Muirhead, et al.
Genes and Immunity|October 12, 2007
Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosisF C McKay, L I Swain, S D Schibeci, et al.
Journal of Autoimmunity|April 15, 2008
CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosisFiona C McKay, Louisa I Swain, Stephen D Schibeci, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 24, 2024
CD34 Chimerism Directed Donor Lymphocyte Infusion With or Without Azacitidine Results in Reduced Relapse and Superior Overall Survival When Full Donor Chimerism is Achieved in Allogeneic Stem Cell Transplant Recipients With Acute Myeloid Leukaemia/Myelodysplastic SyndromeJoanne Lc Tan, David J Curtis, Jenny Muirhead, et al.
Transplantation and Cellular Therapy|March 26, 2023
Peripheral Blood CD34 Donor Chimerism has Greater Clinical Utility Than CD3 for Detecting Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic SyndromeTongted P Das, Daniel North, Shaun A Fleming, et al.
Pageof 1